Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Breast Neoplasms 10 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 5 Head and Neck Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Squamous Cell 5 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Prostatic Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Esophageal Neoplasms 3 Urinary Bladder Neoplasms 2 Non-small-cell Lung Cancer With Somatic EGFR Mutations 2 Hematologic Neoplasms 2 Glioma 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Unilateral HER2 Positive Breast Cancer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Cancers of the Head and Neck 1 Solid Tumors 1

Interventions

Etoposide 78 Carboplatin 67 Cisplatin 46 durvalumab 26 Topotecan 26 atezolizumab 20 Radiotherapy 19 Irinotecan 19 Paclitaxel 17 anlotinib 16 apatinib 15 Nivolumab 15 Drug Therapy 12 pembrolizumab 9 Platinum 9 toripalimab 8 tislelizumab 8 Gemcitabine 8 Bevacizumab 8 Temozolomide 7 Radiosurgery 7 PM 01183 7 Ipilimumab 7 Pemetrexed 6 Docetaxel 6 Albumin-Bound Paclitaxel 6 olaparib 5 amrubicin 5 Sunitinib 5 surufatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Small Cell Lung Carcinoma × Afatinib × Clear all

NCT02876081 2017-09-11

THEN

Fondation Hôpital Saint-Joseph

Phase 2 Withdrawn

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡